Press Releases

and/or
555 News Releases found
Deb Schrag
Deb Schrag, MD, MPH, Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center, Named President of the American Society of Clinical Oncology

Deb Schrag, MD, MPH, FASCO, gastrointestinal medical oncologist and George J. Bosl Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK), has been elected 2027-28 President of the American Society of Clinical Oncology (ASCO), the world's leading professional organization for physicians and oncology professionals caring for people with cancer.
Cycle for Survival Kicks Off the 2026 Season, Celebrates 20 Years of Impact, and Welcomes NoBull as Apparel Partner
Cycle for Survival Kicks Off the 2026 Season, Celebrates 20 Years of Impact, and Welcomes NOBULL as Apparel Partner

Official rare cancer fundraising program of Memorial Sloan Kettering Cancer Center to host its stationary-cycling events in 16 locations nationwide. Instructors from Equinox, Cycle for Survival’s founding partner, will lead the high-energy rides.
Jason Lewis
Memorial Sloan Kettering Cancer Center Radiochemist, Jason Lewis, PhD, Elected to the National Academy of Inventors

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Jason Lewis, PhD, has been elected as a Fellow of the National Academy of Inventors (NAI), a prestigious honor recognizing individuals who have demonstrated innovation and made tangible contributions to the advancement of technology and society.
Lorenzo Falchi
Study Led by Memorial Sloan Kettering Investigators Shows Three-Agent Combination Demonstrates Promising Efficacy for Relapsed Follicular Lymphoma

Researchers from Memorial Sloan Kettering Cancer Center (MSK) announced today that the latest results from that follicular lymphoma clinical trial have shown the three-drug combination — rituximab (Rituxan®) and lenalidomide (Revlimid®), along with epcoritamab (Epkinly®) — works better than using the two drugs alone. The findings were presented at the American Society of Hematology Annual Meeting (ASH) on December 7, 2025. The findings were also published in The Lancet.
MSK Awards and Appointments October and November 2025

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:Omar Abdel-Wahab Elected to the National Academy of ...
Memorial Sloan Kettering Cancer Center Issues Statement on Third Quarter 2025 Financial Results

Memorial Sloan Kettering Cancer Center (MSK) issued the following statement regarding its financial results for the first three quarters of 2025:
Paul Marks Prize
Three Investigators Named Winners of Memorial Sloan Kettering Cancer Center’s 2025 Paul Marks Prize for Cancer Research

Memorial Sloan Kettering Cancer Center (MSK) will award three influential cancer researchers with this year’s Paul Marks Prize for Cancer Research. The prize, named in honor of former MSK president Paul Marks, MD, recognizes a new generation of leaders who are making significant contributions to the understanding of cancer or are improving the treatment of the disease.
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center is the Best Oncology Hospital in the World according to Newsweek

Memorial Sloan Kettering Cancer Center (MSK) is ranked the number one hospital in the world for oncology according to Newsweek’s World’s Best Specialized Hospitals 2026 list.
Omar Abdel-Wahab
Memorial Sloan Kettering Cancer Center Physician-Scientist Elected to the Prestigious National Academy of Medicine

Omar Abdel-Wahab, MD, Chair of the Molecular Pharmacology Program at Sloan Kettering Institute (SKI); Evnin Family Chair in Molecular Pharmacology and Attending Physician on the Leukemia Service at Memorial Sloan Kettering Cancer Center (MSK), has been elected to the National Academy of Medicine (NAM), one of the most prestigious honors in the fields of health and medicine.
Ross Levine
Ross Levine, MD, Named Chief Scientific Officer of Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) announced today that Ross Levine, MD, has been named MSK’s new Chief Scientific Officer (CSO). A renowned physician-scientist, Dr. Levine previously served as Senior Vice President of Translational Research in Memorial Hospital (MH) and holds the Edward P. Evans Endowed Chair for Myelodysplastic Syndromes at MSK.